HealthFDA Approves RevMed’s Breakthrough Pill for Pancreatic Cancer
Revolution Medicines won US regulatory approval for daraxonrasib, its pancreatic cancer drug and the first medicine designed to target one of the disease’s key molecular causes.
B
Bloomberg News★★★☆☆2026-08-26 15:30Original
FDA Approves RevMed’s Breakthrough Pill for Pancreatic Cancer
Health